No results for ‘’
3B Blackbio DX Ltd
₹1419.90
(1.62%)
Sun, 13 Sept 2026, 10:16 am
Process Industries
Chemicals: Agricultural
24.5K3B Blackbio DX Price to Sales Ratio (P/S)
| Particulars | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Price to earnings ratio | 0 | 21.59 | 10.95 | 19.19 | 0 | 12.94 | 12.45 | 22.92 | 15.19 | 19.49 | 24.89 | 9.21 | 7.07 | 1.87 | 7.94 | 12.01 | 20.54 | 29.05 |
| Price to book ratio | 0 | 0.77 | 0.70 | 1.87 | 0.97 | 0.54 | 0.48 | 0.52 | 0.48 | 1.98 | 4.68 | 2.15 | 1.70 | 1.62 | 1.67 | 1.82 | 2.96 | 5.17 |
| Price to sales ratio | 0 | 0.38 | 0.30 | 0.73 | 0.43 | 0.26 | 0.22 | 0.28 | 0.29 | 1.36 | 3.68 | 2.07 | 1.88 | 0.94 | 3.17 | 5.04 | 8.90 | 14.36 |
| Price to cash flow ratio | 0 | 38.44 | 3.27 | 0 | 0 | 0 | 0 | 0 | 31 | 0 | 70.56 | 15.53 | 8.10 | 2.19 | 5.70 | 12.48 | 24.58 | 32.03 |
| Enterprise value | 0 | 8.55Cr | 7.56Cr | 18.12Cr | 13.08Cr | 10.69Cr | 11.12Cr | 12.31Cr | 12.27Cr | 30.31Cr | 89.67Cr | 51.32Cr | 50.63Cr | 196Cr | 248Cr | 279Cr | 601Cr | 1319Cr |
| Enterprise value to EBITDA ratio | 0 | 8.58 | 6.27 | 10.29 | 12.20 | 8.16 | 8.49 | 9.16 | 8.14 | 10.70 | 16.52 | 7.11 | 5.43 | 1.31 | 6.69 | 9.57 | 18.21 | 26.17 |
| Debt to equity ratio | 0 | 0.43 | 0.34 | 0.42 | 0.61 | 0.62 | 0.69 | 0.74 | 0.74 | 0.78 | 0.32 | 0.27 | 0.11 | 0.02 | 0.02 | 0.01 | 0 | 0 |
| Return on equity % | 0 | 0 | 6.60 | 9.68 | -0.14 | 4.28 | 3.86 | 2.31 | 3.25 | 10.48 | 23.26 | 25.67 | 28.13 | 138.70 | 22.59 | 16 | 16.28 | 19.41 |
3B Blackbio DX Ltd Price to Sales Ratio
The 3B Blackbio DX Ltd Price to Sales Ratio is a key financial metric used by investors to evaluate 3B Blackbio DX Ltd's valuation, profitability, and overall financial performance. Tracking the 3B Blackbio DX Ltd Price to Sales Ratio helps investors understand whether the stock is undervalued, fairly valued, or trading at a premium compared to its historical performance and industry peers.
3B Blackbio DX Ltd (NSE: , BSE: 532067) is currently trading at ₹1419.90, with a market capitalization of ₹1241.4Cr. As a leading company in the Process industries sector and Chemicals: agricultural industry, monitoring the 3B Blackbio DX Ltd Price to Sales Ratio is essential for fundamental analysis.
3B Blackbio DX Ltd Price to Sales Ratio Current Value
The current 3B Blackbio DX Ltd Price to Sales Ratio stands at 14.36.
The latest 3B Blackbio DX Ltd Price to Sales Ratio has increased compared to the previous period, indicating rising valuation or improved investor sentiment.
3B Blackbio DX Ltd Price to Sales Ratio Historical Trend
The 3B Blackbio DX Ltd Price to Sales Ratio has shown the following historical trend:
- 2024: 14.36
- 2023: 8.90
- 2022: 5.04
- 2021: 3.17
- 2020: 0.94
The recent rise in 3B Blackbio DX Ltd Price to Sales Ratio suggests strengthening valuation trends and improving market sentiment.
What 3B Blackbio DX Ltd Price to Sales Ratio Indicates for Investors
The 3B Blackbio DX Ltd Price to Sales Ratio plays a crucial role in understanding the company's financial health and valuation.
The P/S ratio helps evaluate valuation relative to company revenue.
3B Blackbio DX Ltd Price to Sales Ratio Analysis Summary
The 3B Blackbio DX Ltd Price to Sales Ratio remains a crucial metric for evaluating the company's valuation and financial stability. Investors tracking 3B Blackbio DX Ltd Price to Sales Ratio should also monitor related metrics such as P/E, P/B, EV/EBITDA, D/E, and ROE to get a complete fundamental picture.
Regular tracking of 3B Blackbio DX Ltd Price to Sales Ratio helps investors make informed decisions based on long-term growth, valuation trends, and financial performance.